…
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 3.15M | 4.85M | 0.27M | 3.14M | 2.78M |
| Net income | 3.15M | 4.85M | 0.27M | 3.14M | 2.78M |
| Selling general administrative | 0.36M | 0.37M | 0.22M | 0.29M | 0.32M |
| Gross profit | - | - | - | 2.20M | 6.40M |
| Ebit | - | 4.61M | 0.19M | 1.76M | 5.66M |
| Ebitda | - | - | - | 1.80M | 5.95M |
| Operating income | - | - | - | 1.80M | 5.95M |
| Other operating expenses | - | 0.12M | 0.10M | 0.11M | 0.12M |
| Interest expense | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Total revenue | 3.71M | 5.36M | 0.59M | 2.43M | 3.23M |
| Total operating expenses | - | - | - | 0.63M | 0.73M |
| Cost of revenue | - | - | - | 0.24M | 0.27M |
| Total other income expense net | - | - | - | 1.34M | -3.17M |
| Net income from continuing ops | 3.15M | 4.85M | 0.27M | 3.14M | 2.78M |
| Net income applicable to common shares | - | 4.21M | -0.22M | 2.58M | 2.10M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 39.10M | 37.81M | 22.93M | 27.18M | 33.63M |
| Other current assets | - | 0.81M | 0.04M | 0.24M | - |
| Total liab | 19.37M | 15.41M | 9.75M | 10.87M | 14.79M |
| Total stockholder equity | 19.73M | 22.40M | 13.19M | 16.31M | 18.84M |
| Other current liab | - | 0.55M | 0.40M | 0.29M | 1.38M |
| Common stock | - | 22.40M | 13.19M | 16.31M | 18.84M |
| Cash | 0.82M | 1.43M | 0.23M | 0.54M | 0.42M |
| Total current liabilities | - | 15.41M | 9.75M | 10.87M | 14.79M |
| Total current assets | - | 2.50M | 0.53M | 0.84M | 0.49M |
| Long term investments | 24.27M | 36.13M | 22.45M | - | 33.14M |
| Net tangible assets | - | 22.40M | 13.19M | 16.31M | 18.84M |
| Short term investments | - | - | - | 26.33M | 33.14M |
| Net receivables | - | 0.25M | 0.26M | 0.07M | 0.07M |
| Accounts payable | 0.35M | 0.34M | 0.21M | - | 0.31M |
| Non current assets total | - | - | - | 0.00M | 0.00M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Change to liabilities | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Total cash from financing activities | - | 10.19M | -4.65M | -8.57M | -2.71M |
| Change to operating activities | - | -0.15M | -0.03M | -0.00M | -0.05M |
| Net income | 3.15M | 4.21M | -0.22M | 2.58M | 2.10M |
| Change in cash | -0.61M | 1.20M | -0.31M | 0.12M | -1.43M |
| Begin period cash flow | 1.43M | 0.23M | 0.54M | 0.42M | 1.85M |
| End period cash flow | 0.82M | 1.43M | 0.23M | 0.54M | 0.42M |
| Total cash from operating activities | 1.13M | -9.00M | 4.35M | 8.68M | 1.27M |
| Issuance of capital stock | 0.88M | 13.32M | - | - | 0.00M |
| Dividends paid | 2.62M | 2.84M | 1.73M | 2.08M | 2.25M |
| Sale purchase of stock | - | - | -2.92M | -6.49M | -0.46M |
| Other cashflows from financing activities | - | -0.29M | -0.29M | -0.29M | -0.29M |
| Change to netincome | - | -13.06M | 4.60M | 6.10M | -0.78M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | 0.18M | -0.15M | -0.03M | -0.00M | -0.05M |
| Other non cash items | -0.00M | -0.23M | - | 8.35M | 2.38M |
| Free cash flow | 1.13M | -9.00M | 4.35M | 8.68M | 1.27M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| PRM-PA Big Pharma Split Corp |
-0.05 0.49% |
10.17 | 2.97 | - | - | - |
| BLK BlackRock CDR (CAD Hedged) |
1.70 5.77% |
31.14 | 25.23 | 18.90 | 6.38 | 2.79 |
| BN Brookfield Corporation |
3.35 5.89% |
60.20 | 94.76 | 11.96 | 1.84 | 2.36 |
| BAM Brookfield Asset Management Ltd |
4.01 5.62% |
75.33 | 31.22 | 25.51 | 22.40 | 9.70 |
| PHYS Sprott Physical Gold Trust |
1.14 2.74% |
42.73 | 3.81 | - | 3.47 | 1.06 |
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
610 Chartwell Road, Oakville, ON, Canada, L6j 4A5
416-649-4541
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.